Portfolio

Neosil

Neosil was founded as a dermatology-focused specialty pharmaceutical company with several products in pre-clinical development and was subsequently sold to Peplin Pharmaceuticals. The company’s core topical anti-infective technology provides broad anti-microbial activity, long duration of activity, and excellent formulation flexibility. The technology is based on the work of polymer chemist Dr. Samuel P. Sawan, a Professor in the Department of Chemistry at the University of Massachusetts, Lowell. Neosil was incubated and initially funded by Shalon Ventures with follow-on financing provided by MPM Capital (www.mpmcapital.com) and Burrill and Co. (www.burrillandco.com).